Neurostimulation has been used for many years and recent advances make it even more helpful for more patients. There are two main types of neurostimulation: spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS).

An implantable pulse generator (IPG) generates mild electrical impulses to interrupt pain signals before they get to your brain. The other part of the system that gets implanted in your body is called a lead. The lead carries the pulses generated by the IPG to the spinal cord or affected nerve to block the pain signal. This will be placed near the area your physician determines to be the one most likely to resolve or lessen your chronic pain.

About the Nalu Neurostimulation System

The Nalu Neurostimulation System is currently FDA cleared for SCS and PNS indications. The Nalu micro-IPG leverages proprietary advanced microelectronics to produce a pain management system that effectively reduces chronic intractable pain while minimizing interference with the patient’s life. Utilizing an external battery and a micro-IPG with the smallest footprint among commercially available IPGs may mitigate some of the most troublesome aspects of implantable neurostimulation therapy.

The Nalu Neurostimulation System is truly Engineered to be more.

A smaller, less invasive implant: Up to 27x smaller than the largest commercially available implantable pulse generator (IPG).
A battery-free, micro-IPG: Power is externally supplied with a replaceable, wearable Therapy Disc, which eliminates the need for an implanted battery and battery replacement surgeries.
Upgrades without surgery: Software can be upgraded wirelessly and without surgery.
Long-lasting use: The micro-IPG has an FDA-cleared label with an expected service life of 18 years for long-term management of chronic intractable pain

Nalu Procedure Animation Video

Nalu Therapy Overview

Nalu has been repeatedly recognized for its revolutionary technology and innovation, including being named as one of the top 100 new products in the world by R&D Magazine. Nalu was also named Gold Winner of the 2021 Medical Design Excellence Award and winner of MedTech Visionaries Award for Best MedTech Company and Best Medical Device in the field of neurology.

Engineered to Be More™:

durABLE

Nalu micro-IPG has the longest service life among commercially available IPGs in the US–18 years
Eliminates battery-replacement surgeries
Highly configurable microchip enables upgrade of system capabilities when approved

livABLE

Designed to fit patient’s lifestyle
Wearable power and control disc is easy to manage
Therapy Disc is easily changed for optimum flexibility
Smartphone control permits discreet system management
Patients report the system is easy to use¹

comfortABLE

Rated comfortable by patients^1-3
Patients describe the Therapy Disc as virtually unnoticeable¹
Nalu micro-IPG allows a minimally invasive procedure

manageABLE

Extensive menu of therapy options
Patient discreetly controls system from smartphone
No need for separate device for patient remote control
Integrated power and control disc helps simplify system management
Feedback controlled energy transfer for consistent therapy output

upgradeABLE

Flexible nPower™ architecture redefines system upgradeability
System capabilities can be expanded by routine software updates
External components can be upgraded as technology evolves

adaptABLE

FDA-cleared for both SCS and PNS indications
Nalu micro-IPG provides more surgical options
Wide range of therapeutic options
Advanced control from familiar smartphone

Additional Resources

Contact Nalu Medical

1. Staats P, Hartley L, Mishra LN, et al. Human Comfort and Feasibility Data from a New, Miniaturized SCS System. presented at: North American Neuromodulation Society (NANS) Meeting; January 17-January 20 2019; Las Vegas.

2. Amirdelfan K, Levy R, Poree L, Staats P. Evaluation of a New, Battery-Free Microstimulator SCS System: Comfort and Ease-of-Use Data (nPower™ study). presented at: North American Neuromodulation Society (NANS) Meeting; January 23-January 26 2020; Las Vegas.

3. Amirdelfan K, Levy R, Poree L, et al. Evaluation Of a New, Battery-Free Micro-Implantable Pulse Generator SCS System: Patient Choice, Comfort and Ease-of-Use Data. presented at: North American Neuromodulation Society (NANS) Meeting; January 23-January 26 2020; Las Vegas.